on 07 Feb 2023
Last Applicant/ Owned by
UPPSALA
SE
Serial Number
79317845 filed on 22nd Jun 2021
Registration Number
6970244 registered on 07th Feb 2023
Correspondent Address
Donna J. Bunton
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Delivery systems in the nature of implantable drug delivery ports for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological Read More
Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology
Delivery systems in the nature of implantable drug delivery ports for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes
Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies
Chemicals for use in industry for production of antibodies and synthetic and natural peptides
No 79317845
No Service Mark
No DJB/2739-271
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th May 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
08th May 2023 | FINAL DISPOSITION PROCESSED |
08th May 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
07th May 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
07th Feb 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
07th Feb 2023 | REGISTERED-PRINCIPAL REGISTER |
06th Feb 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
18th Jan 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
18th Jan 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
22nd Nov 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |